🇺🇸 FDA
Patent

US 7674778

Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine

granted A61PA61P1/04A61P11/06

Quick answer

US patent 7674778 (Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61P, A61P1/04, A61P11/06, A61P17/00, A61P19/02